Learn more

UNUM THERAPEUTICS INC

Overview
  • Total Patents
    26
  • GoodIP Patent Rank
    61,646
  • Filing trend
    ⇧ 133.0%
About

UNUM THERAPEUTICS INC has a total of 26 patent applications. It increased the IP activity by 133.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ICELL GENE THERAPEUTICS LLC, AMPSOURCE BIOPHARMA SHANGHAI INC and IMMUNEONCO BIOPHARMACEUTICALS SHANGHAI CO LTD.

Patent filings per year

Chart showing UNUM THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ettenberg Seth 16
#2 Motz Gregory 15
#3 Mcginness Kathleen 14
#4 Hickman Taylor 14
#5 Cheema Tooba 14
#6 Huet Heather 12
#7 Fray Michael 10
#8 Wilson Charles 8
#9 Hemphill James 7
#10 O'Callaghan Katie 7

Latest patents

Publication Filing date Title
WO2020097346A1 ANTI-GPC3 CHIMERIC ANTIGEN RECEPTORS (CARs) IN COMBINATION WITH TRANS CO-STIMULATORY MOLECULES AND THERAPEUTIC USES THEREOF
WO2020051493A1 Chimeric receptor polypeptides in combination with trans metabolism molecules modulating intracellular lactate concentrations and therapeutic uses thereof
WO2020037066A1 Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating krebs cycle and therapeutic uses thereof
WO2020028572A2 ANTIBODY-COUPLED T CELL RECEPTORS (ACTRs) IN COMBINATION WITH TRANS CO-STIMULATORY MOLECULES AND THERAPEUTIC USES THEREOF
WO2020010110A1 Chimeric receptors in combination with trans metabolism molecules enhancing glucose import and therapeutic uses thereof
CN110582298A Combined use of anti-BCMA antibodies and antibody-coupled T cell receptors (ACTRs) in cancer therapy and B cell disease
AU2018213407A1 Improved antibody-coupled T cell receptor constructs and therapeutic uses thereof
WO2018027135A1 Treatment of lymphoma using antibody-coupled t cell receptor
EP3487877A1 Use of antibody-coupled t cell receptor (actr) with multiple anti-cancer antibodies in cancer treatment